Novartis Cough/Cold OTCs Boost Consumer Health Division In Q1
This article was originally published in The Tan Sheet
Executive Summary
Novartis' over-the-counter sales achieved double-digit growth in its first quarter on the strength of cough and cold brands and expansion into new markets, particularly Japan, the company said
You may also be interested in...
Novartis OTC Division Is “Fastest Growing” Among Industry Leaders – CEO
Novartis Consumer Health showed "strong performance" in 2006 with full year net sales of $7.53 billion, according to earnings results announced during a fourth-quarter and year-end call Jan. 18
Nestle Looks To Cook Up Nutrition Product Sales With Novartis MN Acquisition
Nestle looks to become the number two company in the healthcare nutrition field, including the infant formula market, with its planned $2.5 bil. acquisition of Novartis' Medical Nutrition unit
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.